Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Credit Acceptance Corporation announced the appointment of Joe Billante as its new Chief Financial Officer, effective July 27, 2026, succeeding Jay Martin who is retiring after 23 years. Billante brings extensive CFO experience from Barracuda Networks, eBay, and GE, expected to guide Credit Acceptance's continued growth and strategic transformation…
Fennec Pharmaceuticals Inc. reported the successful election of its director nominees at the annual general and special meeting held online. Shareholders also approved the appointment of auditors, executive compensation, and amendments to the 2020 Equity Incentive Plan with strong support.
Nyxoah SA completed a $95 million equity financing and expects an additional $15 million tranche from a European Investment Bank loan, totaling $110 million in new capital. This financing will accelerate the U.S. commercialization of its Genio system, a leadless, battery-free hypoglossal neurostimulation therapy for Obstructive Sleep Apnea (OSA). T…
Snow Rothschild Acquisition Corp., a special purpose acquisition company (SPAC), has closed its initial public offering of 20 million units at $10 per unit, raising $200 million. Units trade on Nasdaq under ticker ISNRU, with Class A shares and warrants expected to trade separately under ISNR and ISNRW. The SPAC aims to pursue mergers or acquisitio…
Oxbridge Re Holdings Limited, through its subsidiary SurancePlus, has announced an agreement with HCI Group to launch three tokenized real-world asset securities linked to reinsurance contracts underwritten by Fortex Reinsurance. These securities, issued on the Solana blockchain via Alphaledger, offer accredited investors exposure to excess-of-loss…
Toll Brothers is offering the final opportunities to purchase new luxury homes at its University Park community in Palm Desert, featuring quick move-in homes and professionally decorated models. The community offers exceptional amenities and prime location advantages, appealing to upscale homebuyers in the region.
Onity Group Inc., a leading non-bank financial services provider specializing in mortgage servicing and originations, announced that its CFO Sean O'Neil will present at the Sidoti Small Cap Virtual Conference on June 17, 2026. The company will also host investor meetings during the event, providing an opportunity to discuss its technology-enabled, …
Fortrea, a global contract research organization, announced the granting of 240,500 restricted stock units to 10 newly hired employees as inducement awards under Nasdaq Listing Rule 5635(c)(4). These RSUs vest in three equal annual installments starting June 10, 2027, to incentivize retention and attract talent. This move aligns with Fortrea's grow…
Methode Electronics, Inc. announced a quarterly dividend of $0.05 per share payable on July 31, 2026, to shareholders of record on July 17, 2026. The company is a global supplier of custom-engineered mechatronic solutions serving sectors such as automotive, cloud computing infrastructure, and industrial markets.
BRT Apartments Corp., a real estate investment trust specializing in multifamily residential properties, announced a quarterly dividend of $0.25 per share payable on July 9, 2026. The company holds interests in 31 multifamily properties across 11 states, reflecting a broad footprint in the residential real estate market.
Oportun, a Nasdaq-listed mission-driven financial services company, announced its participation in the Sidoti June Virtual Investor Conference. Key executives will present Oportun's business and strategy, accessible live and via replay to investors.
Nyxoah SA, a medical technology company specializing in solutions for Obstructive Sleep Apnea (OSA), has successfully closed an underwritten public offering raising approximately $95 million. The proceeds will be used to expand commercialization activities in the US and other markets, advance product development including Genio system upgrades, and…
Globus Maritime Limited reported Q1 2026 results showing a 42% increase in revenue to $12.2 million and adjusted EBITDA up to $6.2 million compared to Q1 2025. Time Charter Equivalent rates increased substantially, reflecting improved market conditions. Despite disruptions from hostilities in the Persian Gulf and resulting supply chain impacts, the…
Rumble Inc. announced its management team will engage in a series of upcoming investor conferences throughout June 2026, including virtual and in-person events. These include Maxim Group's AI Data Center Summit, the 16th Annual ROTH London Conference, and the Northland Growth Conference. The company aims to connect with institutional investors and …
Nasdaq held its 2026 Annual Meeting of Shareholders where all 12 nominated directors were elected for one-year terms, including the re-election of Adena T. Friedman as Chair of the Board. Shareholders also approved executive compensation on an advisory basis and ratified Ernst & Young LLP as the independent auditor for fiscal year 2026.
Cytek Biosciences, a Nasdaq-listed company specializing in advanced cell analysis solutions, announced its participation in the Singular Research's Las Vegas Invitational Conference from June 14-16, 2026. The company management will present on June 15th, with live and archived webcasts available. Cytek is known for its proprietary Full Spectrum Pro…
RadNet, a leading US outpatient diagnostic imaging services provider, secured a $250 million incremental term loan maturing in 2031, alongside a 0.25% interest rate reduction on its term loan and revolving credit facility. The proceeds will finance acquisitions, expansions, health system partnerships, and general corporate purposes, supporting RadN…
ZOOZ Strategy Ltd. announced that its Board of Directors has authorized management to explore a range of strategic alternatives that could complement its existing bitcoin treasury strategy, aiming to enhance long-term shareholder value. The review includes potential business combinations, acquisitions, partnerships, or capital initiatives but reaff…
Solidion Technology Inc. has successfully closed a $35 million private placement of common stock priced above market under Nasdaq rules. The proceeds fully fund the company through 2028, enabling accelerated commercialization of its patented Extreme-Climate Battery technology aimed at the Lunar economy, space applications, AI data center UPS system…
Oxford Industries announced its fiscal 2026 first quarter results with net sales nearly flat at $391 million compared to $393 million last year. Adjusted EPS declined due to increased tariff costs, softer sales at Lilly Pulitzer, and challenging market conditions. Tommy Bahama led growth with mid-single-digit gains, while Johnny Was and Lilly Pulit…
Humacyte, a Nasdaq-listed biotechnology company focused on bioengineered human tissues, has commenced an underwritten public offering of its common stock to raise funds for commercializing its FDA-approved product Symvess, filing a BLA supplement for hemodialysis, advancing pipeline product candidates, and for general corporate purposes. The offeri…
Celldex announced multiple presentations showcasing data from its mast cell-targeting therapies barzolvolimab and CDX-622 at the 2026 European Academy of Allergy and Clinical Immunology Annual Congress. Data includes Phase 1 results for CDX-622 and robust Phase 2 data on barzolvolimab in treating chronic spontaneous urticaria and cold urticaria, re…
Tectonic Therapeutic has completed enrollment for its 24-week APEX Phase 2 clinical trial evaluating the safety and efficacy of TX45 in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). The trial enrolled 191 patients across 14 countries, focusing on those with the more severe combined p…
Concentrix Corporation, a Fortune 500 technology and services company specializing in integrated human and AI solutions, will release its fiscal second quarter 2026 financial results after market close on June 29, 2026. The company will also hold a conference call and webcast to discuss results on the same day.
Humacyte announced positive interim results from its V012 Phase 3 study showing that its acellular tissue engineered vessel (ATEV) provides significantly more catheter-free days compared to the current standard of care, autologous AV fistula, in female dialysis patients. The trial met its primary endpoint with a strong statistical significance, lea…
